Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.75 |
| ▸ | TAS2R38 | P59533 | 2/20 | 0.75 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | TYR | P14679 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.73 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.73 |
| ▸ | HPGD | P15428 | 1/20 | 0.73 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | GAA | P10253 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | KIF11 | P52732 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12071790 | 0.89 | ALDH1A1 (0.62) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL728343 | 0.89 | ALDH1A1 (0.62) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL1822006 | 0.89 | ALDH1A1 (0.65) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL652231 | 0.87 | IDO1 (0.63) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL145719 | 0.87 | IDO1 (0.63) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL449122 | 0.87 | ALDH1A1 (0.60) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL5518697 | 0.87 | IDO1 (0.63) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL11751583 | 0.87 | ALDH1A1 (0.61) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL526059 | 0.87 | MAPT (0.63) | ALDH1A1TAS2R38TP53TYRTSHR | |
| SCHEMBL1278440 | 0.87 | ALDH1A1 (0.61) | ALDH1A1TAS2R38TP53TYRTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005915-A | Preparation method and application of lithium anode modified material | 深圳欣界能源科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117645338-A | Method for degrading antibiotics in water body by using thiourea covalent organic framework photocatalyst | 湖南大学 | 2024-03-05 | — | — | CN | claimed |
| CN-117488289-A | Chemical nickel plating method | 中新联科环境科技(安徽)有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-116130607-A | Preparation method and application of solid sulfur anode | 哈尔滨工业大学 | 2023-05-16 | — | — | CN | claimed |
| CN-108690584-B | Composite profile control agent | 中国石油天然气集团有限公司 | 2021-01-29 | — | — | CN | claimed |
| CN-109233778-B | High-temperature antioxidant corrosion inhibitor for gas injection flooding injection well | 中国石油天然气集团有限公司 | 2021-01-01 | — | — | CN | claimed |
| CN-108823570-B | Environment-friendly anti-oxidation corrosion inhibitor for oilfield ground gathering and transportation pipeline and preparation method thereof | 中国石油天然气集团有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-109518171-B | Chemical nickel plating solution | 广州传福化学技术有限公司 | 2020-10-27 | — | — | CN | claimed |
| CN-111733404-A | Chemical nickel plating solution and preparation method thereof | 广州皓悦新材料科技有限公司 | 2020-10-02 | — | — | CN | claimed |
| CN-108559979-B | Chemical nickel plating solution and preparation method thereof | 永星化工(上海)有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-108165959-B | Chemical copper plating solution | 永星化工(上海)有限公司 | 2020-02-07 | — | — | CN | claimed |
| US-20140058111-A1 | PROCESS OF MANUFACTURING BENZOBISTHIAZOLE BUILDING BLOCKS FOR CONJUGATED POLYMERS | PHILLIPS 66 COMPANY (US) | 2014-02-27 | — | — | US | claimed |
| EP-1252172-A2 | COMPOUND COMPRISING A PEPTIDE MOIETY AND AN ORGANO-SILANE MOIETY | VBC-Genomics Bioscience Research GmbH (AT) | 2002-10-30 | — | — | EP | claimed |
| EP-1250344-A2 | COMPOUND COMPRISING A NUCLEIC ACID MOIETY AND AN ORGANO-SILANE MOIETY | VBC-Genomics Bioscience Research GmbH (AT) | 2002-10-23 | — | — | EP | claimed |
| WO-2001046214-A2 | COMPOUND COMPRISING A NUCLEIC ACID MOIETY AND AN ORGANO-SILANE MOIETY | VBC-GENOMICS BIOSCIENCE RESEARCH GMBH (AT) | 2001-06-28 | — | — | WO | claimed |
| WO-2001046213-A2 | COMPOUND COMPRISING A PEPTIDE MOIETY AND AN ORGANO-SILANE MOIETY. | VBC-GENOMICS BIOSCIENCE RESEARCH GMBH (AT) | 2001-06-28 | — | — | WO | claimed |
| EP-1110967-A1 | Compound comprising a biomolecule moiety and an organo-silane moiety | LION Bioscience AG (DE) | 2001-06-27 | — | — | EP | claimed |
| JP-61268688-A | — | — | None | — | — | JP | disclosed |
| US-4522745-A | NITROGEN CONTAINING RING;POSSIBLY CONTAINING OXYGEN, SULFUR, SELENIUM OR TELLURIUM | CHEVRON RESEARCH COMPANY (US) | 1985-06-11 | — | — | US | disclosed |
| JP-S57167-A | ELECTRICALLY CONDUCTIVE RESIN COMPOSITION FOR ELECTROPLATING | TOKYO INK KK | 1982-01-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140058111-A1 | PROCESS OF MANUFACTURING BENZOBISTHIAZOLE BUILDING BLOCKS FOR CONJUGATED POLYMERS | CYP1B1, TUBB4B, DDC | ALDH1A1 215/4885TAS2R38 1041/4885TP53 4370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.